Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v4-EN
Language French English
Date Updated 2024-11-28 2024-11-28
Drug Identification Number 02031116 02031116
Brand name LAMISIL LAMISIL
Common or Proper name LAMISIL TAB 250MG 2 X 14 LAMISIL TAB 250MG 2 X 14
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients TERBINAFINE TERBINAFINE
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 2 X 14 2 X 14
ATC code D01BA D01BA
ATC description ANTIFUNGALS FOR SYSTEMIC USE ANTIFUNGALS FOR SYSTEMIC USE
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2025-03-01 2025-03-01
Actual discontinuation date
Remaining supply date 2025-08-31 2025-08-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments